3rd Party Medical Device Industry News

Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in Japan

Eisai and Biogen Japan will continue to contribute to the [...]

By |2024-11-26T09:12:12+00:00November 26, 2024|3rd Party Medical Device Industry News|Comments Off on Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in Japan
Go to Top